Human Chorionic Gonadotropin Market Size (By Technology: Natural Source Extraction, and Recombinant Technology; By Therapeutic Area: Female Infertility Treatment, Male Hypogonadism, Oligospermia Treatment, and Others; By End-User: Fertility Clinics, Research Institutions, and Others) – Global Industry Analysis, Market Size, Opportunities and Forecast 2021 – 2028

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 250

CHAPTER 1. Industry Overview of Human Chorionic Gonadotropin Market

1.1. Definition and Scope 

1.1.1. Definition of Human Chorionic Gonadotropin

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Human Chorionic Gonadotropin Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Human Chorionic Gonadotropin Market By Technology

1.2.3. Human Chorionic Gonadotropin Market By Therapeutic Area

1.2.4. Human Chorionic Gonadotropin Market By End-User

1.2.5. Human Chorionic Gonadotropin Market By Regions


CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Source

2.2.2. Primary Source


CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restrain 1

3.2.2. Restrain 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Human Chorionic Gonadotropin Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Human Chorionic Gonadotropin Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2020

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players


CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020

4.2. R&D Status of Human Chorionic Gonadotropin Major Manufacturers in 2020


CHAPTER 5. Human Chorionic Gonadotropin Market By Technology

5.1. Introduction

5.2. Human Chorionic Gonadotropin Market Revenue By Technology

5.2.1. Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast, By Technology, 2017-2028

5.2.2. Natural Source Extraction

5.2.2.1. Natural Source Extraction Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

5.2.3. Recombinant Technology

5.2.3.1. Recombinant Technology Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028


CHAPTER 6. Human Chorionic Gonadotropin Market Revenue By Therapeutic Area

6.1. Introduction

6.2. Human Chorionic Gonadotropin Market Revenue (US$ Mn) By Therapeutic Area

6.2.1. Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

6.2.2. Female Infertility Treatment

6.2.2.1. Female Infertility Treatment Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

6.2.3. Male Hypogonadism

6.2.3.1. Male Hypogonadism Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

6.2.4. Oligospermia Treatment

6.2.4.1. Oligospermia Treatment Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

6.2.5. Others

6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028


CHAPTER 7. Human Chorionic Gonadotropin Market Revenue By End-User

7.1. Introduction

7.2. Human Chorionic Gonadotropin Market Revenue (US$ Mn) By End-User

7.2.1. Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

7.2.2. Fertility Clinics

7.2.2.1. Fertility Clinics Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.3. Research Institutions

7.2.3.1. Research Institutions Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.4. Others

7.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028


CHAPTER 8. North America Human Chorionic Gonadotropin Market By Country 

8.1. North America Human Chorionic Gonadotropin Market Overview

8.2. U.S.

8.2.1. U.S. Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

8.2.2. U.S. Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

8.2.3. U.S. Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

8.3. Canada

8.3.1. Canada Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

8.3.2. Canada Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

8.3.3. Canada Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

8.4. North America PEST Analysis


CHAPTER 9. Europe Human Chorionic Gonadotropin Market By Country

9.1. Europe Human Chorionic Gonadotropin Market Overview

9.2. U.K.

9.2.1. U.K. Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

9.2.2. U.K. Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

9.2.3. U.K. Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

9.3. Germany

9.3.1. Germany Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

9.3.2. Germany Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

9.3.3. Germany Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

9.4. France

9.4.1. France Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

9.4.2. France Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

9.4.3. France Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

9.5. Spain

9.5.1. Spain Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

9.5.2. Spain Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

9.5.3. Spain Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

9.6. Rest of Europe

9.6.1. Rest of Europe Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

9.6.2. Rest of Europe Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

9.6.3. Rest of Europe Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

9.7. Europe PEST Analysis


CHAPTER 10. Asia Pacific Human Chorionic Gonadotropin Market By Country

10.1. Asia Pacific Human Chorionic Gonadotropin Market Overview

10.2. China

10.2.1. China Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

10.2.2. China Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

10.2.3. China Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

10.3. Japan

10.3.1. Japan Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

10.3.2. Japan Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

10.3.3. Japan Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

10.4. India

10.4.1. India Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

10.4.2. India Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

10.4.3. India Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

10.5. Australia

10.5.1. Australia Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

10.5.2. Australia Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

10.5.3. Australia Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

10.6. South Korea

10.6.1. South Korea Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

10.6.2. South Korea Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

10.6.3. South Korea Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

10.7.2. Rest of Asia-Pacific Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

10.7.3. Rest of Asia-Pacific Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

10.8. Asia Pacific PEST Analysis


CHAPTER 11. Latin America Human Chorionic Gonadotropin Market By Country

11.1. Latin America Human Chorionic Gonadotropin Market Overview

11.2. Brazil

11.2.1. Brazil Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

11.2.2. Brazil Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

11.2.3. Brazil Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

11.3. Mexico

11.3.1. Mexico Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

11.3.2. Mexico Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

11.3.3. Mexico Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

11.4. Rest of Latin America

11.4.1. Rest of Latin America Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

11.4.2. Rest of Latin America Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

11.4.3. Rest of Latin America Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

11.5. Latin America PEST Analysis


CHAPTER 12. Middle East & Africa Human Chorionic Gonadotropin Market By Country 

12.1. Middle East & Africa Human Chorionic Gonadotropin Market Overview

12.2. GCC

12.2.1. GCC Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

12.2.2. GCC Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

12.2.3. GCC Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

12.3. South Africa

12.3.1. South Africa Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

12.3.2. South Africa Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

12.3.3. South Africa Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028

12.4.2. Rest of Middle East & Africa Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By Therapeutic Area, 2017-2028

12.4.3. Rest of Middle East & Africa Human Chorionic Gonadotropin Market Revenue (US$ Mn) and Forecast By End-User, 2017-2028

12.5. Middle East & Africa PEST Analysis


CHAPTER 13. Player Analysis Of Human Chorionic Gonadotropin Market

13.1. Human Chorionic Gonadotropin Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Human Chorionic Gonadotropin Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements


CHAPTER 14. Company Profile

14.1. Merck & Co., Inc

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Market Revenue (US$ Mn), 2020

14.1.3.2. Merck & Co., Inc. 2020 Human Chorionic Gonadotropin Business Regional Distribution

14.1.4. Product/Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Bristol Myers Squibb Company

14.3. Fresenius Kabi AG

14.4. Cigna

14.5. Sun Pharmaceutical Industries Ltd

14.6. Ferring Pharmaceuticals Inc

14.7. Scripps Laboratories

14.8. Lee BioSolutions Inc

14.9. Sanzyme

14.10. LUPIN

Cart Summary